|

ABBV-400 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • AbbVie1

Indications

  • Platinum Resistant High Grade Epithelial Ovarian Cancer1
  • Hormone Receptor+/Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer1
  • Liver Disease1
  • Biliary Tract Cancers1
  • Pancreatic Ductal Adenocarcinoma1

Duarte, California1 trial

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

City of Hope National Medical Center /ID# 258645

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.